IRVINE, CA--(MARKET WIRE)--Sep 26, 2007 -- HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) announced today that the joint marketing program with Abbott Laboratories has commenced in Southern Ontario, Canada. The program is the first of its kind and offers Rheumatologists the option of prescribing "combination therapy" for patients with advanced rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
